EC I and Capital Dynamics acquire Crestani S.r.l., a leading Italian manufacturer of glass ampoules and vials, to consolidate their position in the pharmaceutical glass industry and enhance innovation in response to growing market demands.

Target Company Overview

Crestani S.r.l., founded in 1950 and based in Vicenza, Italy, specializes in the production of high-technology ampoules and vials catering to both pharmaceutical and cosmetic industries. The company is renowned for its ability to manufacture non-standard products tailored to the unique specifications of its clients. With a strong export orientation, Crestani generates approximately 80% of its revenue from international markets, solidifying its position as a trusted supplier to a diverse range of pharmaceutical enterprises.

Industry Overview in Italy

The pharmaceutical glass industry in Italy has been experiencing significant growth, driven primarily by increasing global demand for high-quality packaging solutions, particularly in the context of the ongoing COVID-19 pandemic which emphasized the importance of vaccine production. Manufacturers in this sector are adapting to evolving regulatory standards and customer expectations, necessitating innovative and highly specialized production capabilities.

Italy holds a prominent position in the global pharmaceutical landscape, characterized by its rich heritage in manufacturing and stringent quality standards. The synergy of tr

View Source

Similar Deals

Fedrigoni Group Papkot

2025

Corporate VC Paper Products (NEC) Italy
Carton Group Europoligrafico, noble-pac, Wrapology

2023

Corporate VC Paper Packaging Wholesale Italy
Ambienta HolwegWeber

2022

Corporate VC Paper Products (NEC) Italy
Brookfield Fosber

2026

Buyout Paper Products (NEC) Italy
Cemex Terra CO2

2025

Corporate VC Cement & Concrete Manufacturing United States of America
360 Capital Resilco Srl - Società Benefit

2025

Series A Construction Materials (NEC) Italy

Entangled Capital SGR and Capital Dynamics

invested in

Crestani S.r.l

in 2021

in a Corporate VC deal

Disclosed details

Revenue: $30M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert